Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders. - sprookjes - yvandenbroek - TriplyDB

Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders.

Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders.

http://www.wikidata.org/entity/Q33403225

about

Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia.ADAMTS13, TTP and Beyond

P2860

Q33406904-D7D43DFB-3589-4871-9DD0-9DBB1CEDBF3A Q37725685-1CA2D116-7820-47E8-A5B2-3022DDDCE0F4

P2860

Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders.

http://www.wikidata.org/entity/Q33403225

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders.

@ast

Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders.

@en

type

label

Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders.

@ast

Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders.

@en

prefLabel

Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders.

@ast

Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders.

@en

P1433

Q33403225-75EC5913-037A-4C74-A714-FA8996165386

P1476

Q33403225-46063F89-A916-4648-A443-C6DB7552D696

P2093

Q33403225-4B4FFA47-6D30-4D47-8811-9F0A6FF68A0F

Q33403225-597A3B10-6777-43DB-949C-6674A0840501

Q33403225-90916B71-3461-4611-92BD-2B27F8295D54

Q33403225-C7CD1E4E-4874-4586-A0B6-8A46FD276C81

Q33403225-D96E68D2-7CE7-4D9D-9B40-3554480A10B7

P2860

Q33403225-05631ED0-4646-4D53-9EF8-1C0CF1540FAD

Q33403225-07962E83-23C3-47C4-91E9-726EEA244549

Q33403225-0964BE8F-379F-4D51-8C1D-76B83B08607C

Q33403225-09F4D816-FE14-48DE-8399-2F33035E007C

Q33403225-0A51110C-C167-4F5E-8F13-BFCE1BA3BFD9

Q33403225-0F56358A-0EF8-4E3D-87F3-4E23A2C6290F

Q33403225-12090229-D1B3-4F1A-828A-6DA7A9978D45

Q33403225-155539DB-EE06-48B3-985D-6641C2844EAF

Q33403225-16370889-A101-4A47-9802-37355B2C06C5

Q33403225-20159D50-3A33-4A6C-939D-C801899EACF5

P304

Q33403225-C9B35721-800F-4C83-9CE0-3FBF3225D61D

P31

Q33403225-C9AF8E4D-DC90-421E-AE30-EA9D294CBAF0

P356

Q33403225-5D0E06A6-1D46-41EC-9522-1EACC779C541

P407

Q33403225-C02D365A-AB8C-4AF4-BA58-9281B6A3BC75

P433

Q33403225-89204375-233D-41AF-8EEE-FAAE749A1117

P478

Q33403225-0C879817-E89B-4FD2-A19E-5941C5DC8E20

P50

Q33403225-1C9D252B-CDCF-44AD-A50F-A67B34AC18D9

P577

Q33403225-9F1C00D8-EC2F-4C47-9D00-817CE0D67812

P5875

Q33403225-272A8889-1C3E-4574-94C8-8587EE054E24

P698

Q33403225-9FB8B4E0-01CD-4A40-B438-6143D674767A

P932

Q33403225-4790BCA0-8EB0-44D0-8A65-6DCDE1669989

P356

BLOOD-2012-06-389445

P1433

P1476

Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders

@en

P2093

Bruce S Sachais

http://www.w3.org/2001/XMLSchema#string

Don L Siegel

http://www.w3.org/2001/XMLSchema#string

Douglas B Cines

http://www.w3.org/2001/XMLSchema#string

Eline T Luning Prak

http://www.w3.org/2001/XMLSchema#string

Keith R McCrae

http://www.w3.org/2001/XMLSchema#string

P2860

High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II

ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura

Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review

Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure.

Crystal structure of human β2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome

{beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome

Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'

Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab

P304

4134-4142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2012-06-389445

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230830672

http://www.w3.org/2001/XMLSchema#string

P698

22966172

http://www.w3.org/2001/XMLSchema#string

P932

3501713

http://www.w3.org/2001/XMLSchema#string